Skip to main content

Hopkinson Craig C.'s Form 4 filing

Alkermes plc. (ALKS) · filed Feb 14, 2025

Accession no.
0001127602-25-004948
Filed
Feb 14, 2025
Trade date
Feb 12-13, 2025
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 8 non-derivative transactions and 4 derivative transactions. Open-market sales total $11.8M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Hopkinson Craig C.CIK 0001730048Officer (EVP R&D, Chief Medical Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 12, 2025Ordinary SharesMOption exerciseAcquired+87,566$20.03+$1,753,946.98151,166Direct
Feb 12, 2025Ordinary SharesMOption exerciseAcquired+111,630$19.34+$2,158,924.2262,796Direct
Feb 12, 2025Ordinary SharesSSaleDisposed−171,813$32.69−$5,616,566.9790,983Direct
Feb 12, 2025Ordinary SharesSSaleDisposed−33,108$33.27−$1,101,503.1657,875Direct
Feb 13, 2025Ordinary SharesMOption exerciseAcquired+108,833$31.93+$3,475,037.69166,708Direct
Feb 13, 2025Ordinary SharesMOption exerciseAcquired+35,586$24.59+$875,059.74202,294Direct
Feb 13, 2025Ordinary SharesSSaleDisposed−35,586$34.02−$1,210,635.72166,708Direct
Feb 13, 2025Ordinary SharesSSaleDisposed−108,833$36.02−$3,920,164.6657,875Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Feb 12, 2025Ordinary SharesMOption exerciseDisposed−87,566$0.00$00Direct
Feb 12, 2025Ordinary SharesMOption exerciseDisposed−111,630$0.00$050,104Direct
Feb 13, 2025Ordinary SharesMOption exerciseDisposed−108,833$0.00$00Direct
Feb 13, 2025Ordinary SharesMOption exerciseDisposed−35,586$0.00$071,172Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)